JACKSON, Miss., May 26, 2020 /PRNewswire/ — Zavation Medical Products (“Zavation” or the “Company”), an innovative designer and manufacturer of high-quality spinal implants, instruments, MIS procedural kits, and biologics headquartered in Flowood, MS, announced the launch of eZspand™, an expandable lumbar interbody fusion device.
eZspand™, the latest addition to Zavation’s portfolio, features unmatched expandable precision paired with continual expansion to provide an optimized fit for each patient. This optimized fit allows for enhancement of structural stability and improved sagittal balance. eZspand™ does not require secondary locking, minimizing procedural steps. Each implant expands to 4.5mm from the insertion height to create a large graft window that facilitates fusion. The benefits of continuous height adjustment (not incremental) up to 4.5mm expansion paired with no secondary locking step separate eZspand™ from its competitors.
Zavation’s market share and active surgeon base continues to rapidly grow given the Company’s ability to adapt to surgeon/patient needs, consistently upgrade its instruments, and engineer devices with incomparable simplicity and precision. Zavation’s sustained investment in research and development will further enhance its expandable technologies and accelerate market share and active surgeon base gains.
“Our product development team’s dedication to creatively blending simplicity and precision in a robust product design has produced an expandable product that we believe is the new gold standard in facilitating patient fusion in a seamless and simplified procedure,” said Jeffrey Johnson, Chief Executive Officer. “With restoration of alignment being of critical importance, the eZspand™ was developed to help surgeons address stability and sagittal alignment, while maximizing lordotic correction. This product is an example of Zavation’s commitment to offering innovative and differentiated products in conjunction with market leading customer service to best serve our surgeons and distributor network.”
INDICATIONS FOR USE
The Zavation eZspand™ PLIF/T-PLIF implants are indicated for spinal fusion procedures to be used with autogenous bone graft in skeletally mature patients. The Zavation eZspand™ PLIF/T-PLIF implants are intended for use at either one level or two contiguous levels in the lumbar spine, from L2 to S1, for the treatment of degenerative disc disease (DDD) with up to Grade I spondylolisthesis. DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. The device is intended to be used in patients who have had six months of non-operative treatment.
ABOUT ZAVATION MEDICAL PRODUCTS, LLC.
Based in Flowood, MS, Zavation designs, engineers, and manufactures a portfolio of spinal hardware and biologics covering key areas including cervical, thoracolumbar, interbody fusion, interventional spine, and minimally invasive surgery. Founded in 2012, Zavation has experienced exceptional growth and created a national network of 150+ distributors across 40+ states. The Company has commercialized over 15 product families since inception. Zavation operates a 30,000 square foot vertically integrated facility in Flowood, MS and a 14,000 square foot facility in Tampa, FL.Through the PanMed transaction in 2018, the Company acquired a disruptive interventional spine portfolio focused on complex balloons, catheters, needles, and instrument kits used in minimally invasive procedures. To learn more information about Zavation and the Company’s suite of products, visit www.zavation.com.
SOURCE Zavation